Literature DB >> 29549172

Transplant outcome for patients with acquired aplastic anemia over the age of 40: has the outcome improved?

Sabrina Giammarco1, Régis Peffault de Latour2, Simona Sica1, Carlo Dufour3, Gerard Socie2, Jakob Passweg4, Nicolaus Kröger5, Eefke Petersen6, Maria Teresa Van Lint7, Rosi Oneto1, Alessio Signori8, Andrea Bacigalupo1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29549172     DOI： 10.1182/blood-2017-09-807859

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  12 in total

Review 1.  Alternative donor transplants for severe aplastic anemia.

Authors:  Andrea Bacigalupo
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Antithymocyte globulin and cyclosporin: standard of care also for older patients with aplastic anemia.

Authors:  Andrea Bacigalupo
Journal:  Haematologica       Date:  2019-02       Impact factor: 9.941

3.  Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 years.

Authors:  Vipul Sharad Sheth; Victoria Potter; Shreyans A Gandhi; Austin Gladston Kulasekararaj; Hugues de Lavallade; Petra Muus; Antonio Pagliuca; Carmel F M Rice; Varun Mehra; Francesco Grimaldi; Shafqat Inam; Linda D Barber; Ghulam J Mufti; Judith C Marsh
Journal:  Blood Adv       Date:  2019-10-22

Review 4.  Aplastic Anemia.

Authors:  Neal S Young
Journal:  N Engl J Med       Date:  2018-10-25       Impact factor: 91.245

5.  [Progress in diagnosis and treatment in the elderly patients with aplastic anemia].

Authors:  W W Qi; R Fu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-01-14

6.  Stem cell transplantation in aplastic anemia: Impact on choices for first line therapy.

Authors:  Andrea Bacigalupo; Sabrina Giammarco
Journal:  Hemasphere       Date:  2019-06-30

7.  Hematopoietic Stem-Cell Transplantation versus Immunosuppressive Therapy in Patients with Adult Acquired Severe Aplastic Anemia: A Cost-Effectiveness Analysis.

Authors:  Meng-Xue Zhang; Qian Wang; Xiao-Qin Wang
Journal:  Int J Gen Med       Date:  2021-07-15

8.  Long-term outcome of a randomized controlled study in patients with newly diagnosed severe aplastic anemia treated with antithymocyte globulin and cyclosporine, with or without granulocyte colony-stimulating factor: a Severe Aplastic Anemia Working Party Trial from the European Group of Blood and Marrow Transplantation.

Authors:  André Tichelli; Régis Peffault de Latour; Jakob Passweg; Cora Knol-Bout; Gérard Socié; Judith Marsh; Hubert Schrezenmeier; Britta Höchsmann; Andrea Bacigalupo; Sujith Samarasinghe; Alicia Rovó; Austin Kulasekararaj; Alexander Röth; Dirk-Jan Eikema; Paul Bosman; Peter Bader; Antonio Risitano; Carlo Dufour
Journal:  Haematologica       Date:  2019-10-03       Impact factor: 9.941

Review 9.  Novel therapeutic choices in immune aplastic anemia.

Authors:  Phillip Scheinberg
Journal:  F1000Res       Date:  2020-09-10

10.  [How I treat refractory sever aplastic anemia].

Authors:  F K Zhang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.